Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMT as an Adjunct Therapy for Adhesive Capsulitis
NCT07497737Phase 4Not yet recruiting
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Dec 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in adhesive capsulitis (AC) (4 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Time to Recovery at 12 months. Planned start Dec 2026; status: not yet recruiting.
02
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT07497737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07497737.